US patent application for cancer-treatment compound granted
Company says its US-based patent application has been granted.
By ScoutQuest · · 2 min read
- Patent Title
- 5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER
- Patent Status
- US-based patent application has been granted
- Patent Scope
- protects a novel class of compounds that effectively inhibit cancer and cancer stem cells
What the company informed the exchanges
The company informed the National Stock Exchange of India Limited and BSE Limited that its United States-based patent application, titled "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER", has been granted. The grant certificate was attached with the disclosure.
What the company says the patent protects
- The patent protects a novel class of compounds.
- According to the company, these compounds effectively inhibit cancer and cancer stem cells.
- The company states this shows significant potential against various cancer types, including breast and prostate.
What the attached grant certificate states
The certificate records that the United States Patent and Trademark Office has received an application for a patent for a new and useful invention, that the requirements of law have been complied with, and that a patent shall be granted under the law. It states that the patent grants to the person(s) having title the right to exclude others from making, using, offering for sale or selling the invention throughout the United States of America, or importing the invention into the United States of America, for the term set out in the relevant US law, subject to payment of maintenance fees.
How to read a patent grant
A patent is a legal right over an invention. It gives the holder the right to stop others from using the invention in the covered territory for the life of the patent. It is distinct from any regulatory or commercial approval for a medicine, which is a separate process.
What a reader can reasonably take away
The disclosure is about an intellectual-property milestone: an application has moved to a granted patent in the United States, in the field of cancer treatment compounds. The company's description of the compounds' potential against cancer types is the company's own characterisation of the invention covered by the patent.
Also from Godavari Biorefineries
Godavari Biorefineries stock up 7% after a big news update; analyst expects momentum to continue
15 Oct 2026
Godavari Biorefineries stock rose after patent application for a cancer treatment drug was granted
15 Oct 2026
Mexican Patent Office grants patent for compounds treating viral infections
2 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.